Advanced glycation end products (AGEs) and receptors for advanced glycation end-products (RAGE) have been implicated in a range of inflammatory diseases including cardiovascular, diabetes, Alzheimer’s disease, and cancers. This evidence concerns the gene AGER and early-onset autosomal dominant Alzheimer disease.